Drugs / Triple viable Bifidobacterium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02060084 | Jan → Dec 2014 | eating disorder, functional gastric disease | Wang Hua | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triple viable Bifidobacterium | “treatment group1 (Triple viable Bifidobacterium 0.5g bid po)” NCT02060084 ↗ |
| Route | Oral | “was orally administered” NCT02060084 ↗ |